Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen to Distribute Altona RT-PCR Ebola Test

NEW YORK (GenomeWeb) — Qiagen announced today it will offer global distribution of the Altona Diagnostics RealStar Ebolavirus RT-PCR Kit 1.0.

Manufactured and developed by Hamburg, Germany-based Altona, the diagnostic kit can detect all known strains of Ebola viruses, including the Zaire strain driving the current epidemic in West Africa.

"We are making Ebola diagnostic workflows accessible to public health authorities, scientists, and healthcare providers through our commercial networks around the world, including in Africa," Qiagen CEO Peer Schatz said in a statement.

The US Food and Drug Administration issued an Emergency Use Authorization for the kit on Nov. 10.

The distribution agreement expands an existing collaboration between the two firms. Qiagen is also distributing the RealStar Filovirus RT-PCR kit, which tests for Ebola and Marburg viruses.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.